Wealth Enhancement Advisory Services’s Vaxcyte PCVX Stock Holding History

Wealth Enhancement Advisory Services’s Portfolio PCVX Stock Details PCVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$229K	Buy	+3,526	New	+$206K	﹤0.01%	3621

Other funds holding PCVX

Virginia Retirement Systems Richmond, Virginia $16.3B AUM 35.33% 1-Year Est. Return

China Universal Asset Management Company Shanghai, China $1.92B AUM 74.14% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

BG Investment Services Hagatna, Guam $673M AUM 14.41% 1-Year Est. Return

Banque Pictet & Cie Geneva 73, Switzerland $14.5B AUM 33.71% 1-Year Est. Return

Inspire Investing Meridian, Idaho $2.37B AUM 29.82% 1-Year Est. Return

Avior Wealth Management Omaha, Nebraska $3.79B AUM 15.36% 1-Year Est. Return

Values First Advisors Gray, Tennessee $213M AUM 20.51% 1-Year Est. Return

SignatureFD Atlanta, Georgia $7.76B AUM 16.09% 1-Year Est. Return

Teza Capital Management Chicago, Illinois $112M AUM 57.58% 1-Year Est. Return

Wealth Enhancement Advisory Services's PCVX Position: Q3 2026 in Review

Wealth Enhancement Advisory Services opened a new position in Vaxcyte (PCVX) in Q3 2026: 3,526 shares worth $229K. The stake represents ﹤0.01% of the portfolio and ranks #3621 among its holdings.

59 funds tracked by Wall St. Rank hold PCVX as of Q3 2026.

Wealth Enhancement Advisory Services held 3,526 shares of Vaxcyte worth $229K as of Q3 2026.
Vaxcyte was a new Wealth Enhancement Advisory Services position in Q3 2026.
Vaxcyte made up ﹤0.01% of Wealth Enhancement Advisory Services's portfolio in Q3 2026, its #3621 holding.
59 funds tracked by Wall St. Rank held Vaxcyte as of Q3 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q3 2026, filed 13 Oct 2026.